About this Research Topic
This Research Topic aims to spark discussion around popular spontaneous articles from 2022 in Cardiovascular Medicine. The field is continuously evolving, therefore we are seeking to understand developments and perspectives on articles that have attracted attention throughout the year.
The chosen manuscripts are:
The Role of Antiplatelet Therapy in Patients With MINOCA
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
Associations Among PCSK9 Levels, Atherosclerosis-Derived Extracellular Vesicles, and Their miRNA Content in Adults With Obesity
T-Cell Subpopulations Exhibit Distinct Recruitment Potential, Immunoregulatory Profile and Functional Characteristics in Chagas versus Idiopathic Dilated Cardiomyopathies
ADAMTS8 Promotes Cardiac Fibrosis Partly Through Activating EGFR Dependent Pathway>/a>
The Role of Cardiac Magnetic Resonance in Myocardial Infarction and Non-obstructive Coronary Arteries
Big Data in Cardiology: State-of-Art and Future Prospects
Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID
Gut Microbiota in Heart Failure Patients With Preserved Ejection Fraction (GUMPTION Study)
Value of the Systemic Immune-Inflammatory Index (SII) in Predicting the Prognosis of Patients With Peripartum Cardiomyopathy
This topic will be summarized by the specialty chief editors in an editorial alongside their vision for the general cardiovascular medicine section.
We welcome Opinions, Perspectives, Hypotheses and Theory, and Mini-Review article types to facilitate this discussion. Please note only papers that are relevant and add a significant contribution to the discussion will be considered.
Keywords: MINOCA, Cardiomyopathy, Cardiac Fibrosis, Myocardial Infarction, Big Data, COVID, Preserved Ejection Fraction
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.